SpectrumDNA, Inc.
Other OTCTotal Valuation
SpectrumDNA, Inc. carries a market capitalization of 580,956.00, placing it among publicly traded companies globally.
| Market Cap | 580,956.00 |
| Enterprise Value | N/A |
Share Statistics
SpectrumDNA, Inc. currently has 69.90M shares outstanding.
| Shares Outstanding | 69.90M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
SpectrumDNA, Inc. trades at a trailing price-to-earnings ratio of 0.10. The price-to-sales ratio is 1.16, and the price-to-book ratio stands at -0.02.
| PE Ratio | 0.10 |
| PS Ratio | 1.16 |
| PB Ratio | -0.02 |
| P/TBV Ratio | -2.10 |
| P/FCF Ratio | -0.49 |
| P/OCF Ratio | -0.49 |
Financial Position
SpectrumDNA, Inc. maintains a current ratio of 0.05, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.05 |
| Quick Ratio | 0.05 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | 0.24 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | 801.96 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
SpectrumDNA, Inc.'s stock has gained approximately 0% over the past 52 weeks. The 50-day moving average sits at 0.01, while the 200-day moving average is 0.01.
| Beta (5Y) | N/A |
| 52-Week Price Change | 0% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.01 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, SpectrumDNA, Inc. generated 150,349.00 in revenue and converted that into 1.80M in net income, yielding earnings per share of 0.03. EBITDA reached -685,866.00, while operating income came in at -693,079.00.
| Revenue | 150,349.00 |
| Gross Profit | 149,609.00 |
| Operating Income | -693,079.00 |
| Pretax Income | -2.34M |
| Net Income | 1.80M |
| EBITDA | -685,866.00 |
| EBIT | -693,079.00 |
| Earnings Per Share (EPS) | 0.03 |
Balance Sheet
Total book value stands at -9.68M, with working capital of -83,092.00 providing operational flexibility.
| Cash & Cash Equivalents | 4,222.00 |
| Total Debt | N/A |
| Net Debt | -4,222.00 |
| Equity (Book Value) | -9.68M |
| Book Value Per Share | -0.14 |
| Working Capital | -83,092.00 |
Cash Flow
SpectrumDNA, Inc. produced -352,718.00 in operating cash flow over the past twelve months. After subtracting -1,200.00 in capital expenditures, free cash flow totaled -353,918.00 - equivalent to -0.01 per share.
| Operating Cash Flow | -352,718.00 |
| Capital Expenditures | -1,200.00 |
| Free Cash Flow | -353,918.00 |
| FCF Per Share | -0.01 |
Margins
SpectrumDNA, Inc. operates with a gross margin of 99.51, reflecting its pricing power and cost economics. The operating margin of -460.98 and net profit margin of 1,198.54 provide insight into operational efficiency.
| Gross Margin | 99.51 |
| Operating Margin | -460.98 |
| Pretax Margin | -1,554.67 |
| Profit Margin | 1,198.54 |
| EBITDA Margin | -456.18 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 12.95 |
| FCF Yield | -202.26 |
Scores
SpectrumDNA, Inc. posts an Altman Z-Score of -3,381.52, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -3,381.52 |